Latest News
Search News
Blood Cancer Awareness Month 2019
1st September 2019
Today marks the start of Blood Cancer Awareness Month. Our researchers are committed to work to understand the biology of blood cancer and harness this knowledge to identify new treatment strategies to help those affected.
Read more
Introducing Dr Barrie Peck
14th August 2019
Introducing new Group Leader, Dr Barrie Peck We are pleased to welcome Dr Barrie Peck to the CRUK Barts Centre as a new Group Leader. We recently spoke with Barrie […]
Read more
Understanding familial leukaemia
8th August 2019
In 2014, the charity Bloodwise awarded a 5-year programme grant to a team from Queen Mary University of London to support research to better understand the nature of the faulty genes responsible for an inherited/familial predisposition to MDS/AML.
Read more
Antibody therapy in pancreatic cancer
31st July 2019
Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion. Called avb6, the protein is present on the surface of more than 80 per cent of pancreatic ductal adenocarcinoma – the most common form of pancreatic cancer – and is vital to increase the successful growth and spread of the tumour cells.
Read more
London Cancer PhD Student Network
25th July 2019
The newly established London Cancer PhD Student network recently held its first event, which attracted over 60 PhD students from across London to the Barts Cancer Institute. Speakers from six institutes gave short chalk talks to describe their research.
Read more
New research funded by PCRF
19th July 2019
The Pancreatic Cancer Research Fund is supporting two new research projects at the Barts Cancer Institute, Queen Mary University of London. The projects, led by Professor Hemant Kocher and Dr Gunnel Halldén, will aim to identify ways to enhance the efficacy of treatments for pancreatic cancer, to ultimately help those affected by this devastating disease.
Read more